Physician Assistant in Bolling Afb, DC Accepting Medicare
9 Physician Assistant nurses found. Showing 1 - 9
 Lauren S. Hicks, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 238 Brookley Ave, Bolling Afb, DC 20332 Phone: 202-767-5536 |
 John Lloyd Chitwood, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 238 Brookley Avenue, Bolling Afb, DC 20332 Phone: 202-404-3603 |
Kurtis Lee Dean, PA-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 238 Brookley Ave, Bolling Afb, DC 20332 Phone: 202-404-3603 |
Taylor Bottari, PA-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 238 Brookley Ave Sw Bldg 1300, Bolling Afb, DC 20032 Phone: 202-404-2544 Fax: 202-404-3197 |
Mr. Clifford C Souder, PHYSICIAN ASSISTANT Physician Assistant Medicare: Medicare Enrolled Practice Location: 238 Brookley Ave Sw, Bolling Afb, DC 20032 Phone: 202-404-6491 |
Amanda Nicole Collins, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 238 Brookley Avenue, Bolling Afb, DC 22032 Phone: 202-404-7932 |
Raquel Tanzswa Hall, PHYSICIAN ASSISTANT Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 238 Brookley Ave Sw Bldg 1300, Bolling Afb, DC 20032 Phone: 202-404-3906 |
Mr. Todd Gray, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 268 Brookley Ave, Bolling Afb, DC 20032 Phone: 202-404-3603 Fax: 202-404-1256 |
Mrs. Robin Christina Abbott, PHYSICIAN ASSISTANT Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 238 Brookley Ave, C/o Leslie Pierson, Bolling Afb, DC 20032 Phone: 202-404-5512 Fax: 202-767-2238 |
News Archive
Positive trial results for transdermal Lidocaine system
Phosphagenics Limited has announced the successful completion of a phase 1 clinical trial that examined the ability of its patented drug delivery system, TPM, to topically deliver the pain relief drug, lidocaine, safely into humans.
Astellas enters into definitive agreement to acquire Ocata
Astellas Pharma Inc. and Ocata Therapeutics, Inc., a biotechnology company focused on the research and development of new therapies in the field of regenerative medicine, primarily cell therapy addressing unmet medical needs in ophthalmology patients, announced today that they have entered into a definitive agreement.
Couples attending cancer counseling together better prepared to ease children's concerns
When women with children attend a counseling session before undergoing genetic testing for breast cancer, they are far more likely than their partners to be up front with their kids about the tests and the potential for cancers being inherited, according to a study released today here at the annual meeting of the National Society of Genetic Counselors.
Broad Institute of MIT researcher honored for groundbreaking research using new gene editing tool
The newest gene editing tool - called CRISPR-Cas9 - is leading to new research possibilities in cell biology and neuroscience. This includes the ability to make transgenic animal models more quickly, which helps researchers better study diseases that affect thousands of people each year.
President to invoke 'Romneycare' to defend health law
President Barack Obama heads to the same room in Boston where the Massachusetts health law was signed to call for bipartisanship to help the Affordable Care Act succeed.
› Verified 6 days ago